Published in Health Business Week, June 5th, 2009
As part of the agreement, TriLink is providing Osmetech with custom oligonucleotides, which are required reagents for the eSensor(R) detection systems.
"TriLink provides high quality reagents which have contributed to the excellent performance of our eSensor(R) products in the marketplace to date," said Osmetech Molecular Diagnostics COO, Pankaj Singhal.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.